Inventor
ERNST JUSTIN T
US15 patents
Patents
15 patentsUS9814718B2Nov 14, 2017
MNK inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC5 citations83
US9669031B2Jun 6, 2017
MNK inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC12 citations83
US9382248B2Jul 5, 2016
Mnk inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC14 citations83
US10577378B2Mar 3, 2020
EIF4A-inhibiting compounds and methods related thereto
EFFECTOR THERAPEUTICS INC6 citations81
US9957277B2May 1, 2018
eIF4A-inhibiting compounds and methods related thereto
EFFECTOR THERAPEUTICS INC6 citations81
US10793551B2Oct 6, 2020
Benzimidazole-indole inhibitors of Mnk1 and Mnk2
EFFECTOR THERAPEUTICS INC2 citations72
US11083727B2Aug 10, 2021
Piperidine-substituted Mnk inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC2 citations71
US11130757B2Sep 28, 2021
Crystalline forms of MNK inhibitors
EFFECTOR THERAPEUTICS INC2 citations70
US10112955B2Oct 30, 2018
Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2
EFFECTOR THERAPEUTICS INC2 citations70
US10000487B2Jun 19, 2018
Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers
EFFECTOR THERAPEUTICS INC5 citations68
US11878015B2Jan 23, 2024
Piperidine-substituted Mnk inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC0 citations61
US11952375B2Apr 9, 2024
Crystalline forms of Mnk inhibitors
EFFECTOR THERAPEUTICS INC0 citations60
US11440917B2Sep 13, 2022
EIF4A-inhibiting compounds and methods related thereto
EFFECTOR THERAPEUTICS INC1 citations60
US11286268B1Mar 29, 2022
EIF4E-inhibiting compounds and methods
EFFECTOR THERAPEUTICS INC1 citations57
US11014926B2May 25, 2021
Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit MNK1 and MNK2
EFFECTOR THERAPEUTICS INC0 citations51